Universitätsklinikum Jena

Hospital


Location: Jena, Germany (DE) DE

ISNI: 0000000085176224

ROR: https://ror.org/035rzkx15

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Structural insights into heme binding to IL-36α proinflammatory cytokine (2019) Wißbrock A, Goradia NB, Kumar A, Paul George AA, Kühl T, Bellstedt P, Ramachandran R, et al. Journal article High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels (2019) Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, et al. Conference contribution Nilotinib Vs Nilotinib Plus Pegylated Interferon a (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response (2019) Hochhaus A, Burchert A, Saussele S, Baerlocher GM, Brummendorf TH, Rosee PL, Heim D, et al. Conference contribution Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia (2019) Röllig C, Kramer M, Schliemann C, Mikesch JH, Steffen B, Krämer A, Sauer T, et al. Journal article Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status (2019) Lyons PA, Peters JE, Alberici F, Liley J, Coulson RM, Astle W, Baldini C, et al. Journal article Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study (2019) Worm M, Bauer A, Elsner P, Mahler V, Molin S, Nielsen TSS Journal article Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108) (2019) Klinghammer K, Gauler T, Dietz A, Grünwald V, Stöhlmacher J, Knipping S, Schroeder M, et al. Journal article Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry (2019) Kraft M, Knop MP, Renaudin JM, Scherer Hofmeier K, Pfoehler C, Bilo MB, Lang R, et al. Journal article S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1 (2019) Mahler V, Nast A, Bauer A, Becker D, Brasch J, Breuer K, Dickel H, et al. Journal article S3-Leitlinie: Durchführung des Epikutantests mit Kontaktallergenen und Arzneimitteln – Kurzfassung Teil 1 (2019) Mahler V, Nast A, Bauer A, Becker D, Brasch J, Breuer K, Dickel H, et al. Journal article